To Tube or Not to Tube? The Role of Intubation during Stroke Thrombectomy by Courtney Takahashi et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MINI REVIEW ARTICLE
published: 23 September 2014
doi: 10.3389/fneur.2014.00170
To tube or not to tube?The role of intubation during stroke
thrombectomy
CourtneyTakahashi 1, ConradW. Liang2, David S. Liebeskind 2 and Jason D. Hinman2*
1 Department of Neurology and Neurocritical Care, Oregon Health and Science University, Portland, OR, USA
2 Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
Edited by:
Edward Manno, Cleveland Clinic, USA
Reviewed by:
Ira Chang, Swedish Medical Center,
USA
Bijoy K. Menon, University of Calgary,
Canada
*Correspondence:
Jason D. Hinman, Department of
Neurology, University of California
Los Angeles, 635 Charles E.Young Dr.
South, Room 415, Los Angeles, CA
90095, USA
e-mail: jhinman@mednet.ucla.edu
In the 10 years since the FDA first cleared the use of endovascular devices for the treat-
ment of acute stroke, definitive evidence that such therapy improves outcomes remains
lacking. The decision to intubate patients undergoing stroke thrombectomy impacts multi-
ple variables that may influence outcomes after stroke.Three main areas where intubation
may deleteriously affect acute stroke management include the introduction of delays in
revascularization, fluctuations in peri-procedural blood pressure, and hypocapnia, resulting
in cerebral vasoconstriction. In this mini-review, we discuss the evidence supporting these
limitations of intubation during stroke thrombectomy and encourage neurohospitalists,
neurocritical care specialists, and neurointerventionalists to carefully consider the decision
to intubate during thrombectomy and provide strategies to avoid potential complications
associated with its use in acute stroke.
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INTRODUCTION – THROMBECTOMY AND INTUBATION
In 2004, the FDA cleared the use of the first clot retrieval device,
the MERCI retriever, for thrombectomy in acute ischemic stroke
up to 8 h after symptom onset (1). A variety of modalities have
been adapted for intracranial thrombectomy including corkscrew
retrieval devices, aspiration thrombectomy, and stent retrievers.
These devices are able to mechanically remove clots that obstruct
blood flow in the intracranial vasculature (2). While a rela-
tively small percentage of all stroke patients undergo mechanical
thrombectomy, this number has increased sixfold from 0.1% of all
stroke cases in 2004 to 0.6% of all stroke cases in 2009 (3).
Despite the initial excitement regarding the possibilities
afforded by mechanical thrombectomy, the results of recent large
randomized trials have been disappointing. Three large trials have
failed to demonstrate the superiority of thrombectomy over tPA
that had been previously expected (4–6). One reason for the
unexpected findings may be related to the high rates of intuba-
tion that occurred when thrombectomy was introduced. Routine
intubation has traditionally been preferred by interventionalists
because it reduces pain and discomfort for the patient and pre-
vents movement during intracranial catheter navigation and clot
retrieval. This improves the ease of performing the procedure and
minimizes the potential risk for iatrogenic vessel dissection or per-
foration. When thrombectomy first became available, most cases
were performed with general anesthesia; very few patients received
conscious sedation. A survey of interventionalists showed a pref-
erence for performing most cases under general anesthesia (7).
These early studies, in which intubated patients were overly rep-
resented may not have captured all the complications associated
with intubation. Most recently, the IMS3 trial data, which were
collected prospectively, but retrospectively analyzed, showed the
increased risks associated with intubation. Among 434 patients,
269 (62%) had their procedure performed under local anesthesia,
while 147 (33.9%) received general anesthesia. Except for slightly
milder strokes in the local anesthesia group (NIHSS 16 vs. 18), the
groups were evenly matched.
Several years after the introduction of thrombectomy, centers
began to utilize conscious sedation, rather than rely exclusively
on general anesthesia. Hence, more recent studies comparing out-
comes in intubation likely had more balanced groups, where the
number of intubated and non-intubated patients was more equal.
When conscious sedation was compared to general anesthesia,
investigators ultimately discovered that intubation was associated
with higher rates of sub-arachnoid hemorrhage and increased
mortality (8). Large, retrospective studies have linked intubation to
worsened outcomes after thrombectomy, including longer hospital
stays and poorer functional outcomes in two large studies (9, 10).
Intubating patients during thrombectomy may actually be
worsening outcomes by changing cerebral blood flow patterns,
increasing minute ventilation, or delaying revascularization (11,
12) (Figure 1). In this mini-review, we review the current data
on these potential complications of intubation and make a case
for avoiding intubation whenever possible during acute stroke
thrombectomy.
TIME IS BRAIN
One robust finding, across multiple clinical stroke trials and ani-
mal models, is the notion that “time is brain.” In essence, shortly
after a clot blocks an artery, ischemia ensues very quickly and
the stroke area rapidly grows. While the “time is brain” approach
assumes a linear relationship between time and brain ischemia
where there likely is not one, an abundance of basic science and
clinical data supports the effort to emphasize rapid treatment of
stroke. A pooled analysis of several large stroke trials showed a
significant benefit (p< 0.02) the earlier tPA is administered, with
patients receiving tPA in <90 min conferring the highest benefit
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FIGURE 1 | Diagram of proposed relationships between general anesthesia and observed higher levels of post stroke disability.
(1) Reprinted by permission from Macmillan Publishers Ltd: Acta Pharmacologica Sinica, Reference 3460241439635 copyright 2011.
(13). The earlier IMS trials demonstrated a 10% decrease in the
likelihood of good outcomes for every 30 min of case delay (14).
A pooled analysis of six major stroke trials also showed that the
number needed to treat (NNT) was significantly lower the closer
patients were to their symptom onset (15) (Table 1).
While time to treatment was not a primary end point in IMS3,
the study still demonstrated the utility of early revascularization.
Patients who received tPA in <90 min had better outcomes and
patients who received earlier thrombectomy had a trend toward
better outcomes (16). Another study, produced using the IMS3
data, demonstrated that in 240 proximal vessel occlusions, angio-
graphic reperfusion (defined as TICI score 2–3) was achieved in
182 (76%) of all patients. The average time to reperfusion was
325 min; the range varied from 180 to 418 min. Increased times to
reperfusion were associated with worse clinical outcomes – every
30 min delay decreased the likelihood of good clinical outcome
(16). Data from the STAR study also show that every 60 min
increase in onset to reperfusion time decreased good outcome by
38% (17). Similarly, the RECANALISE trial, a prospective study
comparing outcomes in patients with confirmed arterial occlu-
sions treated with IV-tPA vs. IV-tPA plus endovascular therapy,
concluded that door to groin puncture times influenced outcomes.
In the IV-tPA plus thrombectomy arm, patients who received
their intervention in <210 min were more likely to have a better
outcome (defined as mRS <2 at 3 months, NIHSS 0–1 24 h post
stroke, or reduction of four NIHSS points 24 h after admission)
compared to patients who received treatment after 210 min. Every
30 min reduction in onset to reperfusion times was associated with
Table 1 | Relationship between time of symptom onset and functional
outcome (measured by modified Rankin scale), after reperfusion
therapy with IV-tPA.
Time (minutes Number needed Number needed
after onset) to treat to harm
0–90 3.6 65
91–180 4.3 38
181–270 5.9 30
271–360 19.3 14
Table based on work by Lansberg et al. (15).
increased likelihood of good clinical outcome in RECANALISE
(18). A pooled analysis from seven different centers demonstrated
a significant association and trend toward increased mortality
as onset to reperfusion times increased (p< 0.001, adjusted OR
1.19, 95% CI 1.05–1.35). Intracerebral hemorrhage was asso-
ciated with longer onset to reperfusion time. Not surprisingly,
favorable and excellent outcomes were associated with shorter
onset to reperfusion times. Overall, this pooled analysis con-
cluded a 20% decreased likelihood of good outcome with every
30 min delay (15).
One major disadvantage to intubation prior to thrombectomy
is the delay in procedure start times. In practical terms, intubation
increases the door to groin puncture times. Given the rich data that
support better outcomes with shorter symptom onset to treatment
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times, unnecessary intubations may result in delayed treatment
times and ultimately higher post stroke disability. A recent study
in Germany examined both retrospective and prospective door
to groin puncture times, after a fast-track intubation system had
been implemented. Prior to the system implementation, intuba-
tion delayed procedure onset times by an average of 51 min. After
the implementation of fast-track program, door to groin punc-
ture times were improved (25± 10 min) but still slower than the
times of patients who arrived previously intubated (19). Hence,
even when streamlined programs in tertiary care centers are
implemented, intubation may produce an unnecessary delay in
procedural start times. At present, the best approach would be
to recommend intubation in patients who may suffer from any
type of cardiorespiratory compromise or suspected impending
airway failure. A streamlined system for intubation is ideal, as it
would be the best way to reduce door to needle times. Hospitals
should strive to reduce intubations for the purpose of procedural
ease, as the current evidence suggests that these procedures may
delay thrombectomy start times and ultimately result in patient
harm (20).
EFFECTS OF INTUBATION ON SYSTEMIC BLOOD PRESSURE
The optimal blood pressure goals in the acute post stroke period
are not clearly defined and remain a controversial topic among
neurologists (21).Post hoc analysis of the International Stroke Trial
reported a “U ”-shaped curve when relating initial blood pressures
to outcome – patients with very low and very high blood pres-
sures tended to have the worst outcomes (22). While it may be
beneficial in some cases to treat elevated blood pressures in the
acute post stroke period (23, 24), it is not beneficial to lower blood
pressures so that the patient becomes systemically hypotensive.
The initial cerebral response to an arterial blockage is an increase
in systemic blood pressure. This increase is transient as the brain
seeks to shunt blood around the blockage by augmenting collateral
flow through smaller arteries and arterioles to perfuse the affected
stroke territory (25).
Many general anesthetic agents lower blood pressure and even
cause frank hypotension (25). Most of the induction agents,
including propofol, one of the most commonly utilized induction
agents, include hypotension as a side effect. While ketamine and
etomidate are the best agents to maintain blood pressure, their use
may be limited. Ketamine can cause post operative psychosis and
etomidate is associated with increased 30 day mortality and cardiac
morbidity (26, 27). Therefore, lower systemic blood pressures and
resultant lower cerebral perfusion pressures caused by vasodilating
general anesthetics may be deleterious to outcomes (25).
In practice, however, the effect of blood pressure in the acute
stroke period and the effects of peri-procedural blood pressures
are difficult to determine. Data on the control of blood pres-
sure in stroke patients treated with endovascular thrombectomy
are limited and reveal mixed results. Some small, retrospective
studies have not shown effects between blood pressure and out-
comes. For instance, a pooled analysis performed on patients
treated with the MERCI device showed that higher pre-treatment
systolic blood pressures were associated with lower revasculariza-
tion rates. The study dichotomized blood pressures into groups
>150 vs.<150 mmHg systolic and found that higher initial blood
pressures resulted in significantly worse rates of revascularization
(28). Similarly, a single retrospective study of acute stroke patients
treated with mechanical thrombectomy looked at the relationship
between changes in blood pressure and functional outcome. The
study patients were acute stroke patients who received mechani-
cal thrombectomy for treatment of their stroke. Outcomes were
dichotomized into “good” outcomes (mRS< 4) vs. “poor” out-
comes (mRS≥ 4). While there was a significant drop in blood
pressure in both groups after induction with general anesthe-
sia, there was no association between blood pressure drops and
functional outcomes at 3 months (11).
However, in a similar single center, retrospective Canadian
study investigators reported an association between low systolic
blood pressures (SBP< 140) and worsened functional outcomes.
Functional outcomes were measured by modified Rankin score,
with score 0–2 considered a “good” outcome. The study demon-
strated lower blood pressures, particularly the lowest blood pres-
sure readings, in intubated patients who received general anes-
thesia. The study also attempted to control for other factors that
may affect outcome after stroke through the use of binary logis-
tic regression analyses to adjust for other factors known to affect
stroke outcomes (age, diabetes, and heart disease), and even con-
sidered highest and lower systolic and diastolic blood pressures.
Using this rigorous approach, the study found an association
between lower intraprocedural blood pressures and outcome (29).
Concrete recommendations regarding blood pressure manage-
ment during and after thrombectomy do not exist. Current studies
are small and retrospective in nature, yet, it is likely that hypoten-
sion and blood pressure lowering in normotensive patients appears
harmful, particularly, in view of the AHA/ASA guidelines that
recommend anti-hypertensive treatment only for patients with
sustained systolic blood pressures over 220 mmHg in the setting
of acute ischemic stroke (30). While consensus data on patients
undergoing thrombectomy does not exist, there is limited clinical
data and pathophysiologic mechanisms to suggest that anesthetic-
induced hypotension in peri-procedural period likely blunts the
presumed protective response in acute stroke.
STRATEGIES TO MINIMIZE BLOOD PRESSURE DROPS
Reperfusion therapies such as thrombectomy are designed to
improve cerebral blood flow, but intubation and adjunctive med-
ications used for intubation frequently worsen cerebral hemody-
namics. Since blood pressure drops are inevitable with induction,
minimizing the use of general anesthesia may be one way to limit
blood pressure changes. Avoidance of the use of the halogenated
anesthetic agents and propofol may result in better outcomes,
since both classes of drugs can cause hypotension through sys-
temic vasodilation (31, 32). An alternative may be etomidate,
as it is less associated with dramatic blood pressure drops (33).
Aggressive treatment of dehydration or under-resuscitation and
hypotension associated with infection may also help to improve
patient outcomes, though this has not been rigorously evaluated
with trial data (28, 30). Hence, when intubation is necessary, we
would recommend setting strict blood pressure guidelines for the
anesthesiologist at the beginning of thrombectomy and augment-
ing anesthetic induction with fluid or pressor support as needed
to maintain a MAP no <15% of the pre-procedural MAP.
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HYPOCAPNIA AND ITS EFFECTS ON CEREBRAL BLOOD FLOW
Intubation and general anesthesia may also result in worsened
neurological outcomes in acute stroke patients because of the
effect of hypocapnia on the arterial system of the brain. Intu-
bated patients are unable to control their respiratory rate – their
respiratory rates are instead controlled by ventilator parameters
and inversely related to arterial CO2 levels (12, 31, 34). By surren-
dering patients’ CO2 levels to a ventilator, the patient may become
relatively hypocapnic, suffer from vasoconstriction, and ultimately
a larger stroke territory with resultant worse functional outcomes
(35). Studies of both EMS providers and anesthesiologists show
that providers have a tendency to hyperventilate neurologically
injured patients (36, 37). Hyperventilation may ultimately lead to
hypocapnia, which causes arterial vasoconstriction and this may
cause decreased perfusion to the ischemic penumbra (12, 34). Even
small differences may have consequences – a 1 mmHg decrease in
CO2 may result in a 3% decrease in arterial flow (34).
Animal models demonstrate that hypocapnic states produce
dysregulation and decreased cerebral blood flow as well. New-
born piglet studies show that hypercapnic vasodilation is lost after
ischemia reperfusion. Interestingly, vasoconstriction in response
to hypocapnia is maintained (38). Rat models have also shown
caudoputamenal damage in response to hypocapnic states associ-
ated with mechanical ventilation (39). Human patients affected
by stroke also show widespread vasoconstriction, even in the
hemisphere contralateral to the stroke territory (40–42).
Clinical evidence also implies that hypocapnia may be associ-
ated with worse clinical outcomes. In post hoc analysis, a small
single center retrospective study found an association between
lower CO2 levels and worsened post stroke functional outcomes
(11). Hypocapnia may cause problems with blood vessel reac-
tivity throughout the cerebral circulation. Small studies of stroke
patients have demonstrated abnormal vessel reactivity in the hemi-
sphere contralateral to the stroke, implying that hypocapnia may
cause widespread depressed cerebral blood flow (43). Another
investigation suggested that in the acute stroke setting, arteries
may be able to vasoconstrict in response to hypocapnia but they
are unable to vasodilate in response to elevated CO2 levels (44).
Anesthesiologists may decide to manage a case with low normal
CO2 levels or mild hypocapnia because they fear normocapnia and
hypercapnia will exacerbate intracranial pressures. Anesthesiolo-
gists may also favor keeping patients slightly hypocapnic because
they often rely on end tidal monitors to evaluate ventilation dur-
ing the case. Because end tidal monitors are unable to account for
CO2 trapped in dead spaces of the lung, end tidal values are typi-
cally lower than arterial CO2. The difference between end tidal and
arterial CO2 levels is even wider when patients have pre-existing
cardiopulmonary disease. Hence, when relying on end tidal mon-
itors, anesthesiologists may target lower CO2 values, presuming
that the arterial values are higher (45, 46).
While there is no definitive evidence such as a large, randomized
control trial regarding the effects of hypocapnia in acute stroke,
animal evidence and small studies suggest that it may have dele-
terious consequences. Hypocapnia may cause vasoconstriction,
while hypercapnia can increase intracranial pressures; hence, until
a randomized human trial is completed, normocapnia is likely the
safest ventilation strategy (12, 26).
CONCLUSION
In the acute stroke setting, recent retrospective evidence suggests
that patients who receive conscious sedation fare better than those
who receive general anesthesia and intubation. This observation
may explain, at least in part, the worsened outcomes experi-
enced by thrombectomy patients when compared to tPA alone (4,
47). The underlying mechanism may be related to delayed treat-
ment times, drops in systemic blood pressure that compromise
the ischemic penumbra or hypocapnia with its associated arter-
ial vasoconstriction. More recent studies posit that the worsened
outcomes may be related to higher risk for aspiration pneumonia
and risk of sepsis in intubated vs. non-intubated patients (48).
Regardless of mechanism, the present studies, albeit most of them
retrospective, suggest increased mortality associated with intu-
bation (9, 10, 49). Likely these contributing factors synergize to
negatively impact patient outcome and should be considered in
future clinical trials of acute stroke management using thrombec-
tomy. The decision to intubate an acute stroke patient should not
be enacted automatically or by institutional ischemic stroke algo-
rithm. Rather this decision should be considered carefully by the
stroke neurologist, neurointerventionalist, and neurocritical care
physicians on an individual patient basis.
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